Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus.
Identifieur interne : 001F33 ( Main/Merge ); précédent : 001F32; suivant : 001F34Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus.
Auteurs : Trevor Scobey [États-Unis] ; Boyd L. Yount ; Amy C. Sims ; Eric F. Donaldson ; Sudhakar S. Agnihothram ; Vineet D. Menachery ; Rachel L. Graham ; Jesica Swanstrom ; Peter F. Bove ; Jeeho D. Kim ; Sonia Grego ; Scott H. Randell ; Ralph S. BaricSource :
- Proceedings of the National Academy of Sciences of the United States of America [ 1091-6490 ] ; 2013.
Descripteurs français
- KwdFr :
- ADN complémentaire (génétique), Amorces ADN (génétique), Attachement viral, Cellules cultivées, Coronavirus (génétique), Dipeptidyl peptidase 4 (métabolisme), Glycoprotéine de spicule des coronavirus (génétique), Glycoprotéine de spicule des coronavirus (physiologie), Humains, Maladies transmissibles émergentes (virologie), Moyen Orient, Polymorphisme de restriction, Protéines luminescentes, Réaction de polymérisation en chaine en temps réel, Régulation de l'expression des gènes viraux (génétique), Régulation de l'expression des gènes viraux (physiologie), Réplication virale (physiologie), Syndrome respiratoire aigu sévère (virologie), Technique de Northern, Technique de Western.
- MESH :
- génétique : ADN complémentaire, Amorces ADN, Coronavirus, Glycoprotéine de spicule des coronavirus, Régulation de l'expression des gènes viraux.
- métabolisme : Dipeptidyl peptidase 4.
- physiologie : Glycoprotéine de spicule des coronavirus, Régulation de l'expression des gènes viraux, Réplication virale.
- virologie : Maladies transmissibles émergentes, Syndrome respiratoire aigu sévère.
- Attachement viral, Cellules cultivées, Humains, Moyen Orient, Polymorphisme de restriction, Protéines luminescentes, Réaction de polymérisation en chaine en temps réel, Technique de Northern, Technique de Western.
English descriptors
- KwdEn :
- Blotting, Northern, Blotting, Western, Cells, Cultured, Communicable Diseases, Emerging (virology), Coronavirus (genetics), DNA Primers (genetics), DNA, Complementary (genetics), Dipeptidyl Peptidase 4 (metabolism), Gene Expression Regulation, Viral (genetics), Gene Expression Regulation, Viral (physiology), Humans, Luminescent Proteins, Middle East, Polymorphism, Restriction Fragment Length, Real-Time Polymerase Chain Reaction, Severe Acute Respiratory Syndrome (virology), Spike Glycoprotein, Coronavirus (genetics), Spike Glycoprotein, Coronavirus (physiology), Virus Attachment, Virus Replication (physiology).
- MESH :
- chemical , genetics : DNA Primers, DNA, Complementary, Spike Glycoprotein, Coronavirus.
- chemical , physiology : Spike Glycoprotein, Coronavirus.
- geographic : Middle East.
- genetics : Coronavirus, Gene Expression Regulation, Viral.
- chemical , metabolism : Dipeptidyl Peptidase 4.
- physiology : Gene Expression Regulation, Viral, Virus Replication.
- virology : Communicable Diseases, Emerging, Severe Acute Respiratory Syndrome.
- Blotting, Northern, Blotting, Western, Cells, Cultured, Humans, Luminescent Proteins, Polymorphism, Restriction Fragment Length, Real-Time Polymerase Chain Reaction, Virus Attachment.
Abstract
Severe acute respiratory syndrome with high mortality rates (~50%) is associated with a novel group 2c betacoronavirus designated Middle East respiratory syndrome coronavirus (MERS-CoV). We synthesized a panel of contiguous cDNAs that spanned the entire genome. Following contig assembly into genome-length cDNA, transfected full-length transcripts recovered several recombinant viruses (rMERS-CoV) that contained the expected marker mutations inserted into the component clones. Because the wild-type MERS-CoV contains a tissue culture-adapted T1015N mutation in the S glycoprotein, rMERS-CoV replicated ~0.5 log less efficiently than wild-type virus. In addition, we ablated expression of the accessory protein ORF5 (rMERS•ORF5) and replaced it with tomato red fluorescent protein (rMERS-RFP) or deleted the entire ORF3, 4, and 5 accessory cluster (rMERS-ΔORF3-5). Recombinant rMERS-CoV, rMERS-CoV•ORF5, and MERS-CoV-RFP replicated to high titers, whereas MERS-ΔORF3-5 showed 1-1.5 logs reduced titer compared with rMERS-CoV. Northern blot analyses confirmed the associated molecular changes in the recombinant viruses, and sequence analysis demonstrated that RFP was expressed from the appropriate consensus sequence AACGAA. We further show dipeptidyl peptidase 4 expression, MERS-CoV replication, and RNA and protein synthesis in human airway epithelial cell cultures, primary lung fibroblasts, primary lung microvascular endothelial cells, and primary alveolar type II pneumocytes, demonstrating a much broader tissue tropism than severe acute respiratory syndrome coronavirus. The availability of a MERS-CoV molecular clone, as well as recombinant viruses expressing indicator proteins, will allow for high-throughput testing of therapeutic compounds and provide a genetic platform for studying gene function and the rational design of live virus vaccines.
DOI: 10.1073/pnas.1311542110
PubMed: 24043791
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001B87
- to stream PubMed, to step Curation: 001B87
- to stream PubMed, to step Checkpoint: 001A74
- to stream Ncbi, to step Merge: 000B52
- to stream Ncbi, to step Curation: 000B52
- to stream Ncbi, to step Checkpoint: 000B52
Links to Exploration step
pubmed:24043791Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus.</title>
<author><name sortKey="Scobey, Trevor" sort="Scobey, Trevor" uniqKey="Scobey T" first="Trevor" last="Scobey">Trevor Scobey</name>
<affiliation wicri:level="2"><nlm:affiliation>Departments of Epidemiology, Cell Biology and Physiology, and Microbiology and Immunology and Cystic Fibrosis/Pulmonary Research and Treatment Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7435.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Caroline du Nord</region>
</placeName>
<wicri:cityArea>Departments of Epidemiology, Cell Biology and Physiology, and Microbiology and Immunology and Cystic Fibrosis/Pulmonary Research and Treatment Center, University of North Carolina at Chapel Hill, Chapel Hill</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Yount, Boyd L" sort="Yount, Boyd L" uniqKey="Yount B" first="Boyd L" last="Yount">Boyd L. Yount</name>
</author>
<author><name sortKey="Sims, Amy C" sort="Sims, Amy C" uniqKey="Sims A" first="Amy C" last="Sims">Amy C. Sims</name>
</author>
<author><name sortKey="Donaldson, Eric F" sort="Donaldson, Eric F" uniqKey="Donaldson E" first="Eric F" last="Donaldson">Eric F. Donaldson</name>
</author>
<author><name sortKey="Agnihothram, Sudhakar S" sort="Agnihothram, Sudhakar S" uniqKey="Agnihothram S" first="Sudhakar S" last="Agnihothram">Sudhakar S. Agnihothram</name>
</author>
<author><name sortKey="Menachery, Vineet D" sort="Menachery, Vineet D" uniqKey="Menachery V" first="Vineet D" last="Menachery">Vineet D. Menachery</name>
</author>
<author><name sortKey="Graham, Rachel L" sort="Graham, Rachel L" uniqKey="Graham R" first="Rachel L" last="Graham">Rachel L. Graham</name>
</author>
<author><name sortKey="Swanstrom, Jesica" sort="Swanstrom, Jesica" uniqKey="Swanstrom J" first="Jesica" last="Swanstrom">Jesica Swanstrom</name>
</author>
<author><name sortKey="Bove, Peter F" sort="Bove, Peter F" uniqKey="Bove P" first="Peter F" last="Bove">Peter F. Bove</name>
</author>
<author><name sortKey="Kim, Jeeho D" sort="Kim, Jeeho D" uniqKey="Kim J" first="Jeeho D" last="Kim">Jeeho D. Kim</name>
</author>
<author><name sortKey="Grego, Sonia" sort="Grego, Sonia" uniqKey="Grego S" first="Sonia" last="Grego">Sonia Grego</name>
</author>
<author><name sortKey="Randell, Scott H" sort="Randell, Scott H" uniqKey="Randell S" first="Scott H" last="Randell">Scott H. Randell</name>
</author>
<author><name sortKey="Baric, Ralph S" sort="Baric, Ralph S" uniqKey="Baric R" first="Ralph S" last="Baric">Ralph S. Baric</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2013">2013</date>
<idno type="RBID">pubmed:24043791</idno>
<idno type="pmid">24043791</idno>
<idno type="doi">10.1073/pnas.1311542110</idno>
<idno type="wicri:Area/PubMed/Corpus">001B87</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001B87</idno>
<idno type="wicri:Area/PubMed/Curation">001B87</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001B87</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001A74</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001A74</idno>
<idno type="wicri:Area/Ncbi/Merge">000B52</idno>
<idno type="wicri:Area/Ncbi/Curation">000B52</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000B52</idno>
<idno type="wicri:Area/Main/Merge">001F33</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus.</title>
<author><name sortKey="Scobey, Trevor" sort="Scobey, Trevor" uniqKey="Scobey T" first="Trevor" last="Scobey">Trevor Scobey</name>
<affiliation wicri:level="2"><nlm:affiliation>Departments of Epidemiology, Cell Biology and Physiology, and Microbiology and Immunology and Cystic Fibrosis/Pulmonary Research and Treatment Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7435.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Caroline du Nord</region>
</placeName>
<wicri:cityArea>Departments of Epidemiology, Cell Biology and Physiology, and Microbiology and Immunology and Cystic Fibrosis/Pulmonary Research and Treatment Center, University of North Carolina at Chapel Hill, Chapel Hill</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Yount, Boyd L" sort="Yount, Boyd L" uniqKey="Yount B" first="Boyd L" last="Yount">Boyd L. Yount</name>
</author>
<author><name sortKey="Sims, Amy C" sort="Sims, Amy C" uniqKey="Sims A" first="Amy C" last="Sims">Amy C. Sims</name>
</author>
<author><name sortKey="Donaldson, Eric F" sort="Donaldson, Eric F" uniqKey="Donaldson E" first="Eric F" last="Donaldson">Eric F. Donaldson</name>
</author>
<author><name sortKey="Agnihothram, Sudhakar S" sort="Agnihothram, Sudhakar S" uniqKey="Agnihothram S" first="Sudhakar S" last="Agnihothram">Sudhakar S. Agnihothram</name>
</author>
<author><name sortKey="Menachery, Vineet D" sort="Menachery, Vineet D" uniqKey="Menachery V" first="Vineet D" last="Menachery">Vineet D. Menachery</name>
</author>
<author><name sortKey="Graham, Rachel L" sort="Graham, Rachel L" uniqKey="Graham R" first="Rachel L" last="Graham">Rachel L. Graham</name>
</author>
<author><name sortKey="Swanstrom, Jesica" sort="Swanstrom, Jesica" uniqKey="Swanstrom J" first="Jesica" last="Swanstrom">Jesica Swanstrom</name>
</author>
<author><name sortKey="Bove, Peter F" sort="Bove, Peter F" uniqKey="Bove P" first="Peter F" last="Bove">Peter F. Bove</name>
</author>
<author><name sortKey="Kim, Jeeho D" sort="Kim, Jeeho D" uniqKey="Kim J" first="Jeeho D" last="Kim">Jeeho D. Kim</name>
</author>
<author><name sortKey="Grego, Sonia" sort="Grego, Sonia" uniqKey="Grego S" first="Sonia" last="Grego">Sonia Grego</name>
</author>
<author><name sortKey="Randell, Scott H" sort="Randell, Scott H" uniqKey="Randell S" first="Scott H" last="Randell">Scott H. Randell</name>
</author>
<author><name sortKey="Baric, Ralph S" sort="Baric, Ralph S" uniqKey="Baric R" first="Ralph S" last="Baric">Ralph S. Baric</name>
</author>
</analytic>
<series><title level="j">Proceedings of the National Academy of Sciences of the United States of America</title>
<idno type="eISSN">1091-6490</idno>
<imprint><date when="2013" type="published">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Blotting, Northern</term>
<term>Blotting, Western</term>
<term>Cells, Cultured</term>
<term>Communicable Diseases, Emerging (virology)</term>
<term>Coronavirus (genetics)</term>
<term>DNA Primers (genetics)</term>
<term>DNA, Complementary (genetics)</term>
<term>Dipeptidyl Peptidase 4 (metabolism)</term>
<term>Gene Expression Regulation, Viral (genetics)</term>
<term>Gene Expression Regulation, Viral (physiology)</term>
<term>Humans</term>
<term>Luminescent Proteins</term>
<term>Middle East</term>
<term>Polymorphism, Restriction Fragment Length</term>
<term>Real-Time Polymerase Chain Reaction</term>
<term>Severe Acute Respiratory Syndrome (virology)</term>
<term>Spike Glycoprotein, Coronavirus (genetics)</term>
<term>Spike Glycoprotein, Coronavirus (physiology)</term>
<term>Virus Attachment</term>
<term>Virus Replication (physiology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>ADN complémentaire (génétique)</term>
<term>Amorces ADN (génétique)</term>
<term>Attachement viral</term>
<term>Cellules cultivées</term>
<term>Coronavirus (génétique)</term>
<term>Dipeptidyl peptidase 4 (métabolisme)</term>
<term>Glycoprotéine de spicule des coronavirus (génétique)</term>
<term>Glycoprotéine de spicule des coronavirus (physiologie)</term>
<term>Humains</term>
<term>Maladies transmissibles émergentes (virologie)</term>
<term>Moyen Orient</term>
<term>Polymorphisme de restriction</term>
<term>Protéines luminescentes</term>
<term>Réaction de polymérisation en chaine en temps réel</term>
<term>Régulation de l'expression des gènes viraux (génétique)</term>
<term>Régulation de l'expression des gènes viraux (physiologie)</term>
<term>Réplication virale (physiologie)</term>
<term>Syndrome respiratoire aigu sévère (virologie)</term>
<term>Technique de Northern</term>
<term>Technique de Western</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>DNA Primers</term>
<term>DNA, Complementary</term>
<term>Spike Glycoprotein, Coronavirus</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="physiology" xml:lang="en"><term>Spike Glycoprotein, Coronavirus</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>Middle East</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Coronavirus</term>
<term>Gene Expression Regulation, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>ADN complémentaire</term>
<term>Amorces ADN</term>
<term>Coronavirus</term>
<term>Glycoprotéine de spicule des coronavirus</term>
<term>Régulation de l'expression des gènes viraux</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Dipeptidyl Peptidase 4</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Dipeptidyl peptidase 4</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Glycoprotéine de spicule des coronavirus</term>
<term>Régulation de l'expression des gènes viraux</term>
<term>Réplication virale</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Gene Expression Regulation, Viral</term>
<term>Virus Replication</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Maladies transmissibles émergentes</term>
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Communicable Diseases, Emerging</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Blotting, Northern</term>
<term>Blotting, Western</term>
<term>Cells, Cultured</term>
<term>Humans</term>
<term>Luminescent Proteins</term>
<term>Polymorphism, Restriction Fragment Length</term>
<term>Real-Time Polymerase Chain Reaction</term>
<term>Virus Attachment</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Attachement viral</term>
<term>Cellules cultivées</term>
<term>Humains</term>
<term>Moyen Orient</term>
<term>Polymorphisme de restriction</term>
<term>Protéines luminescentes</term>
<term>Réaction de polymérisation en chaine en temps réel</term>
<term>Technique de Northern</term>
<term>Technique de Western</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Severe acute respiratory syndrome with high mortality rates (~50%) is associated with a novel group 2c betacoronavirus designated Middle East respiratory syndrome coronavirus (MERS-CoV). We synthesized a panel of contiguous cDNAs that spanned the entire genome. Following contig assembly into genome-length cDNA, transfected full-length transcripts recovered several recombinant viruses (rMERS-CoV) that contained the expected marker mutations inserted into the component clones. Because the wild-type MERS-CoV contains a tissue culture-adapted T1015N mutation in the S glycoprotein, rMERS-CoV replicated ~0.5 log less efficiently than wild-type virus. In addition, we ablated expression of the accessory protein ORF5 (rMERS•ORF5) and replaced it with tomato red fluorescent protein (rMERS-RFP) or deleted the entire ORF3, 4, and 5 accessory cluster (rMERS-ΔORF3-5). Recombinant rMERS-CoV, rMERS-CoV•ORF5, and MERS-CoV-RFP replicated to high titers, whereas MERS-ΔORF3-5 showed 1-1.5 logs reduced titer compared with rMERS-CoV. Northern blot analyses confirmed the associated molecular changes in the recombinant viruses, and sequence analysis demonstrated that RFP was expressed from the appropriate consensus sequence AACGAA. We further show dipeptidyl peptidase 4 expression, MERS-CoV replication, and RNA and protein synthesis in human airway epithelial cell cultures, primary lung fibroblasts, primary lung microvascular endothelial cells, and primary alveolar type II pneumocytes, demonstrating a much broader tissue tropism than severe acute respiratory syndrome coronavirus. The availability of a MERS-CoV molecular clone, as well as recombinant viruses expressing indicator proteins, will allow for high-throughput testing of therapeutic compounds and provide a genetic platform for studying gene function and the rational design of live virus vaccines.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001F33 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 001F33 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= MersV1 |flux= Main |étape= Merge |type= RBID |clé= pubmed:24043791 |texte= Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/RBID.i -Sk "pubmed:24043791" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd \ | NlmPubMed2Wicri -a MersV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |